0
Ocugen, Inc. Banner Image

Ocugen, Inc.

  • Ticker OCGN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Ocugen, Inc. Logo Image
  • 11-50 Employees
  • Based in Malvern, Pennsylvania
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases. Their breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug – “one to many” and their novel biologic product candidate aims to offer better therapy to patients with underserved diseasesMore such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy.
REPORT RATINGS
4.8 / 5.0 (165)

Ocugen, Inc. reports have an aggregate usefulness score of 4.8 based on 165 reviews.

Ocugen, Inc.

Most Recent Annual Report

Ocugen, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Ocugen, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!